At BioAstra, our team of innovators and world-class scientists is redefining the frontiers of healthcare and space exploration. Guided by a shared mission, we integrate groundbreaking technologies to tackle the most challenging environments, bridging critical gaps in health access and driving transformative change on Earth and beyond
A leading genomics and space biology expert, Dr. Mason co-led NASA’s Twins Study, enabled DNA sequencing in space, and founded the MetaSUB Consortium. At BioAstra, he drives AI and genomics innovations.
Chairman
A visionary leader in healthcare and space innovation, Savi co-founded BioAstra to pioneer medical research for Earth and beyond. With expertise in data science and health tech, she has led groundbreaking initiatives in clinical research, AI, and digital health.
Chief Executive Officer
A genomic scientist specializing in astronaut health, Dr. Overbey led analyses of the SpaceX Inspiration4 mission and spearheaded the Space Omics and Medical Atlas (SOMA). As BioAstra’s Chief Scientific Officer, she advances healthcare innovations for astronauts and space medicine.
Chief Scientific Officer
Dr. Tyra is a global philanthropy and international political expert. He leads strategy and resource development and fosters high-impact collaborations across aerospace, pharma, and research sectors.
Chief Strategy and Development Officer
A nuclear-trained naval officer, physicist, and U.S. Naval Academy physics professor, Commander West brings 30 years of naval expertise in submarines, combat readiness, and celestial physics.
Mission DIrector
A machine learning and computational biology expert, Dr. Galeano has pioneered AI-driven drug discovery, from target prediction to antiviral research. With experience at Yale, NASA GeneLab, and COV-IRT, he advances RNA-based therapeutics and space health solutions at BioAstra.
Staff Scientist
A leader in space biomedical research, Prof. Borg spearheaded Malta’s Project Maleth, studying microbiomes in microgravity. His NIH-backed work at BioAstra explores genetic and cellular responses to spaceflight, unlocking insights for astronaut health and transformative Earth-based medicine.
Staff Scientist
A pioneer in genomic science, Professor Church leads Synthetic Biology at the Wyss Institute and has developed groundbreaking genome engineering tools. A key figure in the Human Genome Project, he has founded multiple biotech companies and holds faculty positions at Harvard and MIT.
An investor and visionary in health, space, and emerging technologies, Esther Dyson is the founder of Wellville and chairman of EDventure Holdings. She serves on the boards of 23andMe and Voxiva and trained as a backup cosmonaut in Star City, Russia.
A serial entrepreneur and CEO of Colossal, Ben Lamm focuses on cutting-edge technology to solve global challenges. He has founded and led multiple tech companies, supports startups in defense and climate, and serves on advisory boards, including the Planetary Society.
An expert in clinical informatics, Dr. Glicksberg applies machine learning to patient health data for personalized medicine. He is an Assistant Professor at Mount Sinai’s Icahn School of Medicine and a member of the Hasso Plattner Institute for Digital Health.
A leader in human performance and systems engineering, Dr. Schmidt develops biomedical solutions for extreme environments, from spaceflight to military operations. His work includes NASA’s Astronaut Digital Twin AI platform and rapid prototyping of novel countermeasures.
An entrepreneur and philanthropist, Kimberly Washington leads Deep Space Biology, driving AI-powered space biotech innovation. She founded Space4Girls to empower young women in STEM and serves on advisory boards for Oxford’s Generation AI, BioAstra, and Leaders on Purpose.
A leader in space biology, Daniela Bezdan heads the Green Space Center and formerly served as Chief Scientific Officer at YURI GmbH. With expertise in microgravity research, astronaut health, and genomics, she has contributed to NASA Twin Studies, ESA projects, and urban microbiome research.
A pioneer in space biomedicine, Dr. Beheshti leads research on space health, radiation biology, and AI-driven biomedical solutions. He directs the Space Biomedicine Program at the University of Pittsburgh and has spearheaded major initiatives, including NASA’s Space Omics and Medical Atlas (SOMA).
Feb
20
An invite only evening at the historic Explorers Club as BioAstra unveils its crewed deep-space program, Twin Astra. An extraordinary series of missions that promise to redefine the frontiers of healthcare, space technology, and global innovation.
Mar
07
Join BioAstra leadership at SXSW to talk about all things future and all things health.
Mar
30
BioAstra co-founder Chris Mason will be speaking at NextMed Health 2025 - a unique interdisciplinary community dedicated to catalyzing and accelerating the arrival of a new, human-centric, technology-enabled health age.
This is important: Space exploration isn’t about escaping the challenges of Earth or simply satisfying our curiosity for the unknown.…
VIEW MORE
Eliah G. Overbey, CSO. Humanity stands at the threshold of a remarkable new chapter in space exploration. For decades, orbital…
VIEW MORE
